Sang Ok Song BS, MS, PhD

Sang is the co-founder and COO of Standigm, Sang Ok Song, PhD is focusing on conceptual design, application and validation of AI models at the interface of AI and biology in order to enhance and accelerate drug discovery. Prior to Standigm, Sang Ok was leading a variety of computational biology activities including bioinformatics and PKPD modeling for antibody drug development at the biotherapeutics lab of the Samsung Advanced Institute of Technology.

Sang Ok has an extensive research experience in mathematical and computational modeling and analysis of chemical, biological systems with leading institutions and organizations, including Cornell University, University of Pittsburgh Medical center. He received a PhD in Chemical engineering from Seoul National University, applying machine learning to chemical process monitoring.